ID   QBC939
AC   CVCL_6942
SY   QBC(939); QBC-939
DR   Wikidata; Q54948794
RX   CelloPub=CLPUB00275;
RX   CelloPub=CLPUB00728;
RX   PubMed=20111907;
RX   PubMed=29913454;
RX   PubMed=35640676;
CC   Population: Chinese.
CC   Doubling time: 23.6 hours (PubMed=20111907).
DI   NCIt; C4436; Cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 13
//
RX   CelloPub=CLPUB00275;
RA   Zach S., Birgin E., Ruckert F.;
RT   "Primary cholangiocellular carcinoma cell lines.";
RL   J. Stem Cell Res. Transplant. 2:1013-1013(2015).
//
RX   CelloPub=CLPUB00728;
RA   Wang S.-G., Han B.-L., Duan H.-C., Chen Y.-S., Peng Z.-M.;
RT   "Establishment of a cell line of extrahepatic bile duct carcinoma.";
RL   Zhonghua Shi Yan Wai Ke Za Zhi 14:67-68(1997).
//
RX   PubMed=20111907; DOI=10.1007/s11033-010-9975-7;
RA   Liu Z.-H., He Y.-P., Zhou Y.-K., Zhang P., Qin H.-L.;
RT   "Establishment and identification of the human multi-drug-resistant
RT   cholangiocarcinoma cell line QBC939/ADM.";
RL   Mol. Biol. Rep. 38:3075-3082(2011).
//
RX   PubMed=29913454; DOI=10.1159/000490210;
RA   Yu G.-Y., Wang X., Zheng S.-S., Gao X.-M., Jia Q.-A., Zhu W.-W., Lu L.,
RA   Jia H.-L., Chen J.-H., Dong Q.-Z., Lu M., Qin L.-X.;
RT   "RA190, a proteasome subunit ADRM1 inhibitor, suppresses intrahepatic
RT   cholangiocarcinoma by inducing NF-KB-mediated cell apoptosis.";
RL   Cell. Physiol. Biochem. 47:1152-1166(2018).
//
RX   PubMed=35640676; DOI=10.1016/j.ajpath.2022.05.007; PMCID=PMC9472155;
RA   Isidan A., Yenigun A., Soma D., Aksu E., Lopez K., Park Y.,
RA   Cross-Najafi A., Li P., Kundu D., House M.G., Chakraborty S.,
RA   Glaser S., Kennedy L., Francis H., Zhang W.-J., Alpini G.D., Ekser B.;
RT   "Development and characterization of human primary cholangiocarcinoma
RT   cell lines.";
RL   Am. J. Pathol. 192:1200-1217(2022).
//